Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML
Wermke M, Kraus S, Ehninger A, Bargou RC, Goebeler ME, Middeke JM, Kreissig C, Von Bonin M, Koedam J, Pehl M, Bornhaeuser M, Einsele H, Ehninger G, Cartellieri M (2021)
Publication Type: Journal article
Publication year: 2021
Journal
Book Volume: 137
Pages Range: 3145-3148
Journal Issue: 22
Involved external institutions
Technische Universität Dresden
Germany (DE)
GEMoaB Monoclonals GmbH
Germany (DE)
Universitätsklinikum Würzburg
Germany (DE)
Cellex Cell Professionals GmbH
Germany (DE)
Germany (DE)
GEMoaB Monoclonals GmbH
Germany (DE)
Universitätsklinikum Würzburg
Germany (DE)
Cellex Cell Professionals GmbH
Germany (DE)
How to cite
APA:
Wermke, M., Kraus, S., Ehninger, A., Bargou, R.C., Goebeler, M.-E., Middeke, J.M.,... Cartellieri, M. (2021). Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML. Blood, 137(22), 3145-3148. https://doi.org/10.1182/blood.2020009759
MLA:
Wermke, Martin, et al. "Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML." Blood 137.22 (2021): 3145-3148.
BibTeX: Download